Skip to main content
logo
Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
13.81
-0.04 (-0.29%)
Mar 18, 2026, 9:44 AM EDT - Market open

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
United States Revenue
629.54M616.68M
United States Revenue Growth
2.08%4.35%
Canada Revenue
221.95M208.89M
Canada Revenue Growth
6.25%8.77%
Europe Revenue
232.18M196.01M
Europe Revenue Growth
18.45%4.52%
Other Geographic Revenue
79.95M78.86M
Other Geographic Revenue Growth
1.38%0.17%
Revenue (Total)
1.16B1.10B
Revenue (Total) Growth
5.74%4.88%

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Sterigenics Revenue
755.78M697.85M
Sterigenics Revenue Growth
8.30%4.61%
Nordion Revenue
187.62M173.36M
Nordion Revenue Growth
8.23%8.04%
Nelson Labs Revenue
220.22M229.23M
Nelson Labs Revenue Growth
-3.93%3.40%
Revenue (Total)
1.16B1.10B
Revenue (Total) Growth
5.74%4.88%

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Service Revenue
995.76M941.82M
Service Revenue Growth
5.73%4.00%
Product Revenue
167.86M158.62M
Product Revenue Growth
5.83%10.39%
Revenue (Total)
1.16B1.10B
Revenue (Total) Growth
5.74%4.88%

Adjusted EBITDA

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Sterigenics Segment Income
412.89M378.17M
Sterigenics Segment Income Growth
9.18%4.41%
Nordion Segment Income
107.58M101.22M
Nordion Segment Income Growth
6.28%4.70%
Nelson Labs Segment Income
73.33M69.18M
Nelson Labs Segment Income Growth
5.99%0.06%
Operating Income (Other)
-231.77M-250.95M
Operating Income (Total)
362.03M297.63M
Operating Income (Total) Growth
21.64%7.57%

Capital Expenditures

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Sterigenics Capital Expenditures
99.38M131.26M
Sterigenics Capital Expenditures Growth
-24.28%-19.50%
Nordion Capital Expenditures
21.83M34.93M
Nordion Capital Expenditures Growth
-37.49%-8.92%
Nelson Labs Capital Expenditures
16.80M12.88M
Nelson Labs Capital Expenditures Growth
30.42%-5.13%
Updated Feb 24, 2026. Data Source: Fiscal.ai.